Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine and Ropivacaine PECS Block for Cardiac Surgery
NCT06636578Phase 4Recruiting
- Sponsor
- Fayoum University
- Start
- Oct 2024
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine in postoperative pain (3 arms), sponsored by Fayoum University. Primary endpoints: Visual Analog Scale Pain Score at 24 hours and Total Opioid Consumption at 24 hours. Started Oct 2024; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06636578.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06636578.